Does Tirzepatide Make You Tired? Fatigue on Compounded Tirzepatide
Yes, tirzepatide can make you tired, though most people never feel it, whether you inject from a pen or a vial. In weight-loss trials of FDA-approved tirzepatide, 5–7% of people reported fatigue, compared with 3% on placebo (Zepbound prescribing information). If you're one of them, you're not imagining it. Glapp, the GLP-1 tracker, lets you log your tiredness each day right next to your tirzepatide doses, so you can see when it comes and watch it ease.
Key numbers
| Number | What it means |
|---|---|
| 5–7% | of people on tirzepatide reported fatigue in weight-loss trials, vs 3% on placebo |
| 11,734 | users currently tracking tirzepatide-related fatigue in Glapp |
Tirzepatide fatigue: what the clinical evidence shows
The best evidence on tirzepatide comes from the FDA-approved versions, Zepbound and Mounjaro, which contain the same molecule. In the pooled weight-loss trials behind Zepbound's prescribing information (958 people on placebo, 2,519 on tirzepatide), fatigue rose slightly with dose:
| Side effect | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Fatigue* | 3% | 5% | 6% | 7% |
*Includes fatigue, weakness (asthenia), lethargy and malaise. Source: Zepbound prescribing information, Table 1.
In SURMOUNT-1, people on tirzepatide lost 15–20.9% of their body weight over 72 weeks, vs 3.1% on placebo. That size of change is part of why some people feel drained.
Why does tirzepatide make you tired?
There's no single proven cause, but three things likely play a part:
- Eating less. Tirzepatide turns down appetite a lot, and fewer calories can mean less energy, especially in the first weeks.
- Fluid loss. Nausea, vomiting and diarrhea can leave you short on fluids, and the prescribing information for this GLP-1 medication warns that this can lead to dehydration.
- A large calorie deficit. Losing weight fast asks a lot of your body while it adjusts.
Dehydration, protein and low iron: common reasons for feeling drained
- Dehydration and electrolytes. When you eat less you usually drink less too, and nausea or diarrhea can drain sodium and potassium. Even mild dehydration feels like low energy.
- Too little food and protein. General guidance is at least 0.8 g of protein per kg of body weight a day, and many experts suggest 1.0–1.2 g/kg during weight loss.
- Low iron, vitamin B12 or vitamin D. These are common causes of tiredness in general, and eating less makes a gap more likely. If fatigue doesn't lift, prescribers often check ferritin (iron stores), B12, vitamin D and thyroid levels.
- Sleep and activity. Poor sleep or a sudden drop in movement add up quickly.
Tiredness that comes with dizziness when you stand up, a racing heart or very dark urine is worth raising with your prescriber sooner rather than later.
Track your tirzepatide fatigue with a GLP-1 tracker app
Tiredness is easy to blame on everything else until you can see it. That's what a GLP-1 tracker is for: log how you feel each day next to your tirzepatide doses, and you're in control. You'll know which day after your shot fatigue hits, how strong it gets and whether it's easing, and you'll walk into your next appointment with facts instead of guesses.
Why Glapp? It's a top-rated GLP-1 tracker used by 100,000+ people, rated 4.8/5 on Trustpilot and the App Store, and 4.6/5 on Google Play. Glapp grew out of Reddit GLP-1 support groups and is built by people who take GLP-1 medications themselves, which is why it handles the everyday side of compounded tirzepatide that brand-name pen trackers skip:
- Built-in dosage calculator. Glapp shows the units for the dose and concentration you enter. Confirm with your pharmacist.
- Vial and supply tracking. Every dose you log comes off your active vial, so you always know what's left, down to the unit.
It's grounded in published clinical trial data and peer-reviewed research, core tracking is free, and you get custom titration curves plus syncing across iPhone, Android and web. Here's how to use it over your first 30 days.
Glapp does not provide medical advice or treat side effects. It shows your daily check-ins against your estimated medication levels so you have structured data to share with your prescriber.
Day 1: Start tracking your fatigue
Use Glapp's daily check-in to record fatigue and rate how severe it feels. Log each dose too.
Daily entries help you see whether your fatigue is getting better, getting worse or staying the same. You'll have a clear record of how you felt, without having to remember every day.
Day 3: Compare symptoms with your estimated tirzepatide level
Glapp estimates your medication level throughout the day using your dose and injection time. Tirzepatide typically reaches its highest blood concentration 8–72 hours after an injection.
Seeing your symptoms alongside this estimate helps you spot when fatigue appears within your shot cycle. As you log more days, you can look for a repeating pattern and know when to pay closer attention.
The medication level is an estimate, not a blood test, and a matching pattern does not prove what caused your symptoms.
Day 7: See how your fatigue changes over time
Open the side-effects chart in the Progress tab and choose the period you want to review. Your daily ratings appear on a timeline, making it easier to see whether a difficult day was an isolated episode or part of a longer trend.
Day 14: Look for patterns in your weekly report
Glapp's weekly progress report brings your logged data together, with dedicated sections showing your side effects and how they change.
Does fatigue tend to return on the same day after your shot? Did it jump after you started a new vial? Does it coincide with changes in hunger or food noise? Reviewing two weeks of entries can help you spot patterns that are easy to miss day by day, and give you specific questions to discuss with your doctor.
Day 30: Bring a clear record to your doctor
After a month, review the bigger picture: is your fatigue becoming less frequent, staying the same or getting worse? Tirzepatide generally reaches a steady repeating level after about four weeks of weekly injections at the same dose.
Create a doctor's report in Glapp and choose the information to include. Your doctor can review your symptom history alongside your doses and progress, giving you a more focused conversation about your treatment.
Start tracking your tirzepatide fatigue in Glapp
Fatigue and dose steps on compounded tirzepatide: units, mg and why measuring matters
Tirzepatide usually starts at 2.5 mg once a week and steps up by 2.5 mg at least four weeks apart, to a maintenance dose between 5 and 15 mg. In the trials, fatigue was slightly more common at higher doses: 5% at 5 mg, 7% at 15 mg.
Tirzepatide from a vial is drawn up with a U-100 insulin syringe, where 1 unit = 0.01 mL. How many mg that holds depends on your vial's concentration:
mg = units × concentration (mg/mL) ÷ 100
| Dose | Units at 10 mg/mL | Units at 20 mg/mL |
|---|---|---|
| 2.5 mg | 25 | 12.5 |
| 5 mg | 50 | 25 |
| 7.5 mg | 75 | 37.5 |
| 10 mg | 100 | 50 |
| 12.5 mg | 125 | 62.5 |
| 15 mg | 150 | 75 |
Example concentrations only. Concentrations vary between pharmacies, so always use the concentration on your vial and your prescriber's or pharmacist's instructions. Over 100 units is more than a U-100 syringe holds. Ask your pharmacist.
If fatigue suddenly gets much worse after a new vial, a new pharmacy or a new syringe size, check your concentration and units first, and call your prescriber or pharmacist.
What to bring to your prescriber
A simple log shows your prescriber the pattern at a glance:
| Week | Dose (mg / units) | Fatigue days | Most tired day after shot | Peak rating | Other side effects logged |
|---|---|---|---|---|---|
| Example 1 | 5 mg / 50 units | 5 | Day 2 | High | Nausea |
| Example 2 | 5 mg / 50 units | 4 | Day 2 | Med | Nausea |
| Example 3 | 5 mg / 50 units | 3 | Day 1 | Med | None |
| Example 4 | 5 mg / 50 units | 2 | Day 2 | Low | None |
Questions you could ask. They're conversation starters, not recommendations; your prescriber decides what, if anything, to change.
- "I'm most tired one to two days after my shot. Is that expected on tirzepatide?"
- "Can you double-check my dose in units against my vial's concentration?"
- "Could I be eating or drinking too little on low-appetite days?"
Frequently asked questions
Does compounded tirzepatide cause more fatigue than Zepbound or Mounjaro?
No trials compare them. When it's the same molecule, the same side effects are expected, but pharmacy-made versions can vary in strength, and a dose higher than intended can make fatigue stronger. Logging your dose in mg helps you and your prescriber spot that.
How long does tirzepatide fatigue last?
For most people, it's a phase. Tiredness tends to be strongest in the first weeks and after each dose increase, while your body adjusts to eating less, and it usually eases once your dose is stable and you're eating, drinking and getting enough protein. If it hasn't improved after a few weeks on the same dose, ask your prescriber about checking iron, B12, vitamin D and thyroid.
How many units of tirzepatide is 2.5 mg?
It depends on your vial's concentration. At 10 mg/mL, 2.5 mg is 25 units on a U-100 syringe; at 20 mg/mL, it's 12.5 units. Always confirm with your vial and pharmacist.
How do I track tirzepatide fatigue?
Log it in Glapp's daily check-in and rate it low, medium or high, with your dose in mg. Glapp shows each rating next to your estimated medication level, so you can see whether it follows your shot.
About the data
Ratings are self-reported and medication levels are estimated from dose and timing, not measured. This page is for information only and is not medical advice; talk to your prescriber about any side effect.
About the author
We're GLP-1 patients and health tech professionals, building Glapp in collaboration with doctors. About us
Sources
- Eli Lilly. Zepbound (tirzepatide) prescribing information, Table 1: pooled weight-reduction trials.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205–16. Trial summary.
- U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss.